Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ProPhase Labs Inc (NASDAQ:PRPH)

2.27
Delayed Data
As of 9:45am ET
 +0.02 / +0.89%
Today’s Change
1.78
Today|||52-Week Range
2.45
+13.50%
Year-to-Date
No recent news for ProPhase Labs Inc.

Today’s Trading

Previous close2.25
Today’s open2.27
Day’s range2.27 - 2.27
Volume343
Average volume (3 months)19,050
Market cap$36.4M
Dividend yield--
Data as of 9:45am ET, 09/21/2017

Growth & Valuation

Earnings growth (last year)+22.73%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+1.99%
P/E ratio2.7
Price/Sales1.63
Price/Book6.45

Competitors

 Today’s
change
Today’s
% change
CTRVContraVir Pharmaceut...-0.00-0.93%
PPHMPPeregrine Pharmaceut...+0.16+0.77%
OREXOrexigen Therapeutic...-0.01-0.43%
NTRPNeurotrope Inc+0.03+0.53%
Data as of 10:10am ET, 09/21/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$21.0M
Annual profit (last year)-$2.9M
Net profit margin-13.65%

Profile

Sector
Consumer Non-Durables
Industry
Household/Personal Care
Chairman, Chief Executive Officer &
IR Contact
Ted William Karkus
Chief Financial &
Accounting Officer
Robert V. Cuddihy
Corporate headquarters
Doylestown, Pennsylvania

Forecasts